Response to "An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation"
Recommended Citation
George J, Farhat N, and Thomas E. Response to "An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation". Am J Health Syst Pharm 2022.
Document Type
Article
Publication Date
8-18-2022
Publication Title
American journal of health-system pharmacy
Medical Subject Headings
Humans; Insulin; Glucagon-Like Peptide 1; Glucagon; Glucagon-Like Peptide-1 Receptor Agonists; GLP-1 agonist; diabetes; insulin; medication taper
PubMed ID
35977884
ePublication
ePub ahead of print
Volume
62
Issue
6
First Page
1792
Last Page
1798
COinS
